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Salmonella enterica uses effector proteins delivered by type III secretion systems (TTSS) to colonize eukaryotic cells. Recent in
vivo studies have shown that intracellular bacteria activate the TTSS encoded by Salmonella pathogenicity island-2 (SPI-2) to
restrain growth inside phagocytes. Growth attenuation is also observed in vivo in bacteria colonizing nonphagocytic stromal
cells of the intestinal lamina propria and in cultured fibroblasts. SPI-2 is required for survival of nongrowing bacteria persisting
inside fibroblasts, but its inductionmode and the effectors involved remain unknown. Here, we show that nongrowing dormant
intracellular bacteria use the two-component systemOmpR-EnvZ to induce SPI-2 expression and the PhoP-PhoQ system to reg-
ulate the time at which induction takes place, 2 h postentry. Dormant bacteria were shown to discriminate the usage of SPI-2
effectors. Among the effectors tested, SseF, SseG, and SseJ were required for survival, while others, such as SifA and SifB, were
not. SifA and SifB dispensability correlated with the inability of intracellular bacteria to secrete these effectors even when overex-
pressed. Conversely, SseJ overproduction resulted in augmented secretion and exacerbated bacterial growth. Dormant bacteria
produced other effectors, such as PipB and PipB2, that, unlike what was reported for epithelial cells, did not to traffic outside the
phagosomal compartment. Therefore, permissiveness for secreting only a subset of SPI-2 effectors may be instrumental for dor-
mancy. We propose that the S. enterica serovar Typhimurium nonproliferative intracellular lifestyle is sustained by selection of
SPI-2 effectors that are produced in tightly defined amounts and delivered to phagosome-confined locations.
The species Salmonella enterica comprises Gram-negative facul-tative intracellular bacteria that cause enteric and systemic dis-
eases in humans and livestock (1). This pathogen uses specialized
type III secretion systems (TTSS), such as those in the Salmonella
pathogenicity islands 1 and 2 (SPI-1 and SPI-2), to inject proteins
into host cells and subvert a large variety of processes, including
cytoskeleton dynamics, vesicular trafficking, and nuclear re-
sponses (2–7). In vitro studies using cultured epithelial cells and
macrophages differentiated the function of these two secretion
systems in a temporal and spatial basis. Thus, bacterial entry and
intracellular proliferation are events associated with activities of
the TTSS of SPI-1 and SPI-2, respectively (2, 3, 8). These roles
were also assigned based on the inability of SPI-1mutants to cause
disease inmice when administered orally (9), indicative of a defect
in penetration of the intestinal barrier. In contrast, SPI-2 mutants
exhibit marked attenuation of virulence following oral and sys-
temic administration (10).
Like other virulence factors, expression of the TTSS encoded
by SPI-1 and SPI-2 is tightly regulated. The SPI-1 TTSS responds
to environmental signals, such as low oxygen tension and high
osmolarity (11), whereas the SPI-2 TTSS is activated in response
to signals encountered by intracellular Salmonella in the phago-
some, including acidic pH (12–16) and limitation of phosphate
andmagnesium (16, 17). These signals are perceived by sensors of
two-component systems that transmit the stimulus to island-en-
coded specific regulators, such as HilD, HilA, and HilF in SPI-1
and the two-component system SsrA-SsrB in SPI-2 (2, 5, 18–20).
Cross-regulation between SPI-1 and SPI-2 has been reported (21,
22), and such functional overlap is also evident at the level of the
effector proteins, some of which are recognized as substrates by
both secretion systems (23, 24). These findings suggest that cross-
talk between SPI-1 and SPI-2 could also occur in intracellular
bacteria, although this aspect remains to be demonstrated. More
recent studies have shown that intracellular bacteria express SPI-1
genes and protein effectors translocated by the TTSS encoded by
this island (25–29). Representative examples are the SPI-1 effector
proteins SopB and SipA. SopB is used by intracellular bacteria to
modulate phagosome trafficking and host cell responses involving
the prosurvival kinase Akt and the nitric oxide synthase (25, 26,
30), whereas SipA acts cooperativelywith the SPI-2 effector SifA to
regulate bacterial intracellular proliferation (31). Conversely,
SPI-2 expression also has been shown to precede bacterial pene-
tration of the intestine (32). This early response could facilitate the
subsequent adaptation of the invading bacteria to the intracellular
lifestyle.
S. enterica serovar Typhimurium behaves differently in cul-
tured phagocytic and nonphagocytic cells, exhibiting the highest
replication rates in epithelial cells (5, 33). In vivo, most of the cells
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colonized by S. Typhimurium in systemic sites are phagocytes,
although colonization of cells distinct from macrophages is also
known (34). Of interest, most in vivo studies reveal a low average
number of intracellular bacteria per infected cell (35), a phenom-
enon also occurring in cultured fibroblasts (36). Unlike the case
for other host cell types, invasion of fibroblasts by S. Typhimu-
rium is followed by a nonproliferative state maintained by patho-
gen regulators, such as the two-component system PhoP-PhoQ,
that prevent pathogen overgrowth. The population of intracellu-
lar bacteria behave in a homogeneous manner inside the fibro-
blast. Thus, most of these bacteria remain in a nongrowing state,
reaching an average progeny of 3 to 4 cells per infected fibroblast at
late infection times (36). In vivo, the PhoP-PhoQ system was re-
ported to attenuate growth of intracellular bacteria located in
nonphagocytic stromal cells present in the lamina propria of the
mouse intestine (29). Recently, bacteria located inside phagocytes
present in mouse organs have been shown to reach high numbers
in the absence of SPI-2 (37). In fibroblasts, SPI-2 and the alterna-
tive sigma factor RpoE are required for survival of the nongrowing
dormant bacteria (36).
Our recent transcriptomic study performed in nongrowing
dormant S. Typhimurium collected from fibroblasts revealed ex-
pression of SPI-1 and SPI-2 genes (29). Of interest, enhanced
SPI-2 expressionwas observed in the overgrowing phoPbacteria at
24 h postinfection (29). Based on these findings, we initially pro-
posed that SPI-2 activity must be finely regulated by nongrowing
dormant bacteria to establish a sustained persistence state. Here,
we describe how SPI-2 is regulated by nongrowing dormant intra-
cellular bacteria and identify which SPI-2 effectors are produced
inside the fibroblast. An unsuspected discrimination of SPI-2 ef-
fectors was observed in these nongrowing intracellular bacteria,
which behave competently for secreting only a subset of effectors.
In addition, some of the SPI-2 effectors analyzed are secreted to
subcellular locations different from those reported for other
nonphagocytic cell types.
MATERIALS AND METHODS
Bacterial strains, nonphagocytic eukaryotic cell lines, and infection
conditions. The S. enterica serovar Typhimurium strains used in this
study are shown in Table S1 in the supplemental material. Bacteria were
grown in Luria broth (LB) at 37°C. When appropriate, kanamycin (30
g/ml) or ampicillin (50 g/ml) was added to the growth media. To
analyze production of SPI-2-related proteins, the PCNminimal medium,
adjusted to pH 5.8, was used as described previously (16). NRK-49F nor-
mal rat kidney fibroblasts (ATCC CRL-1570) and HeLa human epithelial
cells (ATCC CCL-2) were used throughout the study. NRK-49F fibro-
blasts were propagated in Dulbecco’s modified Eagle’s medium (DMEM)
(Invitrogen) containing 5% (vol/vol) fetal bovine serum (FBS) and 4mM
L-glutamine. Minimum essential medium Eagle (MEM) containing 10%
FBS was used to grow HeLa cells. For infection of fibroblasts or epithelial
cells, bacteria were grown at 37°C in static nonaerated cultures obtained
upon inoculation of 2 ml of LB medium with a bacterial colony and
subsequent overnight incubation (final optical density at 600 nm [OD600]
of 1.0). Infection was carried out for 20 min using a multiplicity of
infection (MOI) of 10:1 (bacteria to eukaryotic cells) as previously de-
scribed (38). After extensive washing, infected cells were incubated in
fresh tissue culturemedium containing 100g/ml gentamicin for the first
2 h postinfection and 10 g/ml for the rest of the experiment. Infected
cells were lysed at the desired postinfection times in phosphate-buffered
saline (PBS), pH 7.4, 1% (vol/vol) Triton X-100. The number of viable
intracellular bacteria was determined by plating.
Construction of chromosomal epitope-tagged genes. The strains
carrying chromosomal 3FLAG- or hemagglutinin (HA)-epitope-tagged
genes were constructed using the method described by Uzzau et al. (39).
Plasmids and oligonucleotides used for this procedure are listed in Table
S2 in the supplementalmaterial. The correct insertion of the epitope at the
3= end of the targeted gene was verified by PCR.
Large-scale infection of cultured fibroblasts to obtain protein from
intracellular bacteria. Large-scale infections were performed essentially
as described previously (29). Briefly,NRK-49F normal rat fibroblasts were
seeded in BioDish-XL 500-cm2 plates (reference 351040; BD Biosciences)
at a density of 2 107 cells per dish and infected for 20 min at an MOI of
10:1 (bacteria to fibroblast). The infected cells were extensively washed
with prewarmed Hank’s balance salt solution (HBSS) and incubated in
fresh culture medium containing 100 g/ml of gentamicin for 1 h. The
culture medium was then replaced with fresh medium containing 10
g/ml gentamicin until the desired postinfection time (1, 2, 6, 8, or 24 h).
Finally, infected fibroblasts were washedwith cold PBS (pH 7.4) and lysed
in a solution (30 ml per plate) containing 0.4% SDS, 1% acidic phenol,
and 19% ethanol in water. After 30min of incubation at 4°C, intracellular
bacteria were collected by centrifugation (27,500  g, 4°C, 30 min) and
washed three timeswith 1ml of a 1% acidic phenol, 19% ethanol solution.
For protein extraction, intracellular bacteria were washed twice with cold
PBS, pH 7.4, recovered by centrifugation (15,000 g, 4°C, 10 min), and
processed as described previously (29). Protein extraction in extracellular
bacteria was performed by following the same treatments as those for
intracellular bacteria with 1% acidic phenol, 19% ethanol, 0.4% SDS.
Subcellular fractionation of infected fibroblast and epithelial cells.
InfectedNRK-49F fibroblasts orHeLa epithelial cells were eithermechan-
ically disrupted or treatedwith TritonX-100 as described byKnodler et al.
(40). Mechanical fractionation was performed to obtain a low-speed pel-
let (P1 fraction) containing nuclei/cytoskeleton and intact bacteria, a
high-speed pellet enriched in plasmamembrane and endomembranema-
terial (P2 fraction), and the soluble cytosolic fraction (S2 fraction). To
assess secretion of the effector protein by intracellular bacteria, the in-
fected cells were fractionated as described previously (40) in extraction
buffer containing 1% (vol/vol) Triton X-100, yielding a soluble fraction
(S) with cytosol and dissolved membranes and an insoluble fraction (P)
containing nuclei and intact intracellular bacteria.
Protease inhibitor treatment to test stability of SPI-2 effectors in
fibroblasts. NRK-49F fibroblasts were incubated for 30 h prior to infec-
tion with protease inhibitor cocktail for tissue culture medium (catalog
no. P1860; Sigma) by following the manufacturer’s instructions (1:400
dilution of stock solution). These cells were infected with the respective S.
Typhimurium strains tagged in SPI2 effectors and fractionated in soluble
and insoluble fraction as described above. Treatment with protease inhib-
itors did not affect bacterial invasion or intracellular survival rates.
Antibodies, Western analysis, and immunofluorescence micros-
copy. The following primary antibodies were used forWestern assays and
immunofluorescence microscopy studies: mouse monoclonal anti-M45,
recognizing an 18-amino-acid peptide of the adenovirus protein E4-6/7
(gift from Michael Hensel, Osnabrück, Germany); mouse monoclonal
5G10, recognizing a rat membrane glycoprotein present in late endo-
somes and lysosomes (gift from J. Bonifacino, NIH, Bethesda, MD);
mouse monoclonal anti-FLAG epitope (cloneM2; Sigma); mouse mono-
clonal anti-HA epitope (clone 16B12; Covance); rabbit polyclonal anti-
OmpA (gift ofH. Schwarz, Tübingen,Germany); rabbit polyclonal anti-S.
Typhimurium lipopolysaccharide (LPS), group B, factors 1:4:5:12 (Difco
Laboratories); mouse monoclonal anti-DnaK from Escherichia coli
(Stressgene); rabbit polyclonal anti-calnexin (Stressgen); and mouse
monoclonal anti--tubulin (Sigma). For immunofluorescence micros-
copy, the following secondary antibodies were used at a 1:500 dilution:
goat polyclonal anti-mouse IgG conjugated to Alexa 405 (Molecular
Probes), goat polyclonal anti-rabbit IgG conjugated to Alexa 488 (Molec-
ular Probes), and goat polyclonal anti-mouse IgG conjugated to Alexa
594. Goat polyclonal anti-mouse or anti-rabbit IgG conjugated to horse-
Núñez-Hernández et al.
222 iai.asm.org Infection and Immunity
radish peroxidase (Bio-Rad) was used as the secondary antibody at a
1:5,000 dilution for Western assays. Infected NRK-49F fibroblasts were
fixed and processed for immunofluorescence microscopy as previously
described (38). Cells were examined in a Leica fluorescence inverted mi-
croscope (DMI6000B).
Statistical analysis. Data were analyzed by one-way analysis of vari-
ance (ANOVA) using Prism version 5.0 with Tukey’s posttest (GraphPad
Software, Inc.). Differences in values with P 0.05 were considered sig-
nificant.
RESULTS
Dissimilar contribution of PhoP-PhoQ and EnvZ-OmpR to
SPI-2 induction in dormant intracellular S. Typhimurium. The
transcriptome obtained in nongrowing dormant intracellular
bacteria collected from fibroblasts reveals enhanced expression of
SPI-1 and SPI-2 genes at a late postinfection time, 24 h (29). Of
interest, at this time intracellular phoP bacteria exhibit higher ex-
pression of the SPI-2 genes than wild-type bacteria, a phenome-
non not observed in SPI-1 genes (Fig. 1A) or in phoP bacteria
growing extracellularly in LB broth (29). These findings suggested
that the PhoP-PhoQ system could actively downregulate SPI-2
expression levels in nongrowing dormant intracellular bacteria.
Such an assumption contrasts with evidence found by others re-
porting a requirement of PhoP-PhoQ for proper SPI-2 activation
(reviewed in reference 18). Alternatively, the transcriptomic data
couldmerely reflect an altered behavior of SPI-2 due to the lack of
this regulatory system. Therefore, the exact contribution of PhoP-
PhoQ and other SPI-2-positive regulators, such as the two-com-
ponent system EnvZ-OmpR (14, 41–43), was assessed in non-
growing dormant bacteria. To this end, we monitored the activity
of the dedicated regulatory system SsrA-SsrB (13, 43, 44). SsrB
protein levels were determined in wild-type, phoP, ompR, and
ompR phoP isogenic strains carrying an ssrB::3FLAG chromo-
somally tagged allele. Intracellular bacteriawere collected at 1, 2, 4,
8, and 24 h upon infection of NRK-49F rat fibroblasts. For com-
parison, extracellular bacteria grown in LB or minimal defined
PCNmedium, known to activate SPI-2 (16), were also examined.
SsrB levels were differentially regulated by PhoP-PhoQ and EnvZ-
OmpR in extracellular bacteria, with a strict requirement for
OmpR in bacteria grown in LB broth (Fig. 1B). In agreement with
the published transcriptomic data (29), SsrB was upregulated in
nongrowing dormant intracellular wild-type bacteria and the
overgrowing phoP mutant at 24 h postinfection (Fig. 1B). None-
theless, SsrB levels differed at earlier postinfection times among
strains. SsrB was detected in nongrowing intracellular wild-type
bacteria from2hpostinfection, whereas it was hardly visible in the
overgrowing phoP mutant at this time (Fig. 1C). Densitometry
analyses confirmed lower levels of SsrB protein in the phoPmutant
at this early postinfection time (Fig. 1C). Interestingly, SsrB rela-
tive levels increased progressively during the course of infection in
nongrowing wild-type bacteria, whereas in the phoPmutant SsrB
levels increased at 8 h postinfection and declined at later times
(Fig. 1C). The amount of SsrB protein was very low or undetect-
able in intracellular ompR and ompR phoP bacteria at all postin-
fection times tested (Fig. 1C). As expected, the expression profile
of chromosomally tagged SPI-2 effectors, such as PipB and SseJ,
matched that of their positive regulator, SsrB, regarding the dis-
similar regulatory roles of PhoP-PhoQ and EnvZ-OmpR (Fig. 1D
and E). Altogether, these observations indicate that, upon entry
into the fibroblast, the PhoP-PhoQ system is primarily involved in
establishing the time at which induction of SPI-2 must be initi-
ated,2 h postinfection, and that SPI-2 expression in nongrow-
ing dormant bacteria is absolutely dependent on the OmpR regu-
lator.
Nongrowing dormant intracellular S. Typhimurium uses a
defined set of SPI-2 effectors to survive inside fibroblasts.More
than 20 effectors are predicted to be secreted by the SPI-2 TTSS (2,
20, 23, 24, 45). Some of these effectors engage diverse host cell
processes, including cytoskeleton dynamics, vesicular trafficking,
host cell death, and inflammatory signals (46). The levels at which
these effectors are produced or secreted in different host cell types
remain poorly understood. Redundancy in function for some
SPI-2 effectors, especially in epithelial cells, has been claimed in
some studies due to the absence of a phenotype for mutants lack-
ing individual SPI-2 effectors (47). Exceptions are SseF, SseG, and
SseJ, for which different studies have reported contrasting data
relative to their requirement for S. Typhimurium proliferation in
HeLa epithelial cells at distinct postinfection times (47–51). In
macrophages, SPI-2 mutants defective in secretion display im-
paired proliferation and survival (13, 52–54). In fibroblasts, the
role of SPI-2 in survival is inferred from the rapid loss of viability
experienced by a mutant defective in SpiA, a structural protein of
the SPI-2 TTSS apparatus (36). Inactivation of SPI-2 in a phoP
mutant (phoP spiA double mutant) reduces the enhanced growth
rate associated with the loss of the PhoP-PhoQ regulatory system
(36). These data indicate that upon entry into fibroblasts, SPI-2
plays an important role in ensuring survival of nongrowing dor-
mant bacteria and that in the artificial nonphysiological case of a
mutational loss of the PhoP-PhoQ system, it can also promote
pathogen intracellular proliferation. We then focused on how
SPI-2 effectors could contribute to survival of dormant bacteria
and analyzed those effectors known that subvert host vesicular
trafficking, such as SifA, SifB, SseF, SseG, SseJ, PipB, and PipB2
(40, 55–58). Isogenic mutants defective in each of these effectors
were tested in fibroblasts together with amutant lacking the SPI-2
structural protein SsaV, used as a negative control of secretion.
Among these strains, the ssaVmutant and those lacking the effec-
tors SseF, SseG, or SseJ lost viability at 24 h postinfection (Fig. 2).
These data supported the idea of nongrowing dormant intracel-
lular S. Typhimurium using exclusively a subset of SPI-2 effectors
to establish a persistence state inside fibroblasts.
SseJ is an SPI-2 effectorwith cholesterol acyltransferase activity
that promotes localization of the Salmonella-containing vacuole
(SCV) to the Golgi area and the formation of Salmonella-induced
filaments (Sifs) (59, 60). Neither of these phenomena are as prom-
inent in Salmonella-infected fibroblasts as in epithelial cells (61).
Since the sseJ mutant exhibited decreased survival in fibroblasts
(Fig. 2), we reasoned that the amount and/or localization of this
effector could differ in infected NRK-49F fibroblasts with respect
to HeLa epithelial cells. Twenty-four hours after infection of
fibroblasts, the chromosomally tagged SseJ-3FLAG protein ac-
cumulated in phagosome-confined regions with scarce amounts
of the effector detected outside the phagosomal compartment
(Fig. 3). No signal was detected in fibroblasts infected with wild-
type bacteria with untagged SseJ protein or with sseJ::3FLAG-
tagged strains having no functional SPI-2 TTSS (data not shown).
The distribution of SseJ in fibroblasts contrasted with that ob-
served in HeLa-infected cells, in which elaborate filamentous
structures containing the effector were observed in cells having
similar bacterial loads (Fig. 3). These findings, obtained with
physiological levels of the effector produced in two distinct
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FIG 1 Distinct contribution of PhoP-PhoQ and OmpR-EnvZ to SPI-2 regulation in dormant intracellular S. Typhimurium. (A) Heat map showing the
expression prolife of S. Typhimurium pathogenicity island genes (SP-1, SPI-2, SPI-3, SPI-4, and SPI-5) in nongrowing (wild-type) and overgrowing bacteria
(phoP mutant) at 24 h postinfection of NRK-49F fibroblasts. As reference, the expression profile of extracellular wild-type bacteria grown to stationary phase
(Extra-WT-ST) is shown. The Venn diagram indicates genes that are expressed at higher levels in intracellular phoP bacteria than in nongrowing dormant
wild-type bacteria, including genes of the SPI-2 regulon. (B) Levels of the SPI-2 regulator SsrB in isogenic strains with an ssrB::3FLAG chromosomal allele and
differences in the functionality of the PhoP-PhoQ andOmpR-EnvZ two-component systems. The analysis was performed in extracellular bacteria grown in rich
(LB) or chemically defined (PCN) nutrient media, and intracellular bacteria were collected at 24 h postinfection. (C) Kinetics revealing the postinfection time
(2 h) at which intracellular dormant bacteria initiate the production of SsrB. Note the delay and reduction in the production of SsrB levels displayed by phoP
and ompR mutants, respectively. Such delay was also observed upon quantification by densitometry of the relative levels of SsrB with respect to the internal
control, OmpA. (D) Expression pattern of the SPI-2 effector protein PipB in extracellular bacteria grown in LB and PCN media and in intracellular bacteria at
24 h postinfection of NRK-49F fibroblasts. Note the correspondence between these data and those obtained for the SPI-2 dedicated regulator SsrB. Kinetics
analysis performed in parallel also showed such similarities. (E) Relative levels of the SPI-2 effector SseJ in intracellular bacteria collected at 24 h postinfection of
NRK-49F fibroblasts. The expression prolife matches those of SsrB and PipB. OmpA and calnexin were used as loading controls.
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nonphagocytic host cell types, indicated that translocated SseJ
traffics differently inside fibroblasts and epithelial cells.
Secretion of the SPI-2 effector PipB by nongrowing intracel-
lular S. Typhimurium is confined to the phagosomal compart-
ment. pipB and pipB2 genes are among the most highly upregu-
lated genes in nongrowing dormant intracellular bacteria located
in fibroblasts (29). In epithelial cells, PipB and PipB2 are enriched
in lipid rafts upon translocation, and PipB2 is required for Sif
formation (40, 62). Moreover, PipB2 targets the motor protein
kinesin-1 (63). Since no prominent Sifs are observed in S. Typhi-
murium-infected fibroblasts, we wondered whether the localiza-
tion of these two effectors could differ in this host cell type. Their
distribution was monitored in NRK-49F fibroblasts using pipB::
3FLAG and pipB2::HA chromosomally tagged isogenic strains.
Unexpectedly, PipB was visualized exclusively in defined loca-
tions confined to the phagosome-containing nongrowing bac-
teria (Fig. 4A and B). No signal was detected in fibroblasts infected
with wild-type bacteria encoding untagged PipB protein or with
pipB::3FLAG-tagged strains mutants having no functional
SPI-2 TTSS (data not shown). The apparent exclusive presence of
PipB in phagosome-confined areas was confirmed by mechanical
fractionation experiments, which demonstrated that PipBwas ab-
sent from membranous material collected as postnuclear pellets
(Fig. 4C, P2 fraction). Fractionation experiments based on non-
ionic detergent (1% Triton X-100)-mediated cell lysis led to the
visualization of part of the PipB molecules in the soluble fraction,
demonstrating that part of the PipB molecules was secreted,
whereas the rest remained in the bacteria (Fig. 4D). Additional
experiments, in which the subcellular distribution of PipB was
monitored together with that of a rat membrane glycoprotein
present in late endosomes and lysosomes recognized by mouse
monoclonal 5G10 (64), unequivocally demonstrated that PipB
translocation is confined to the phagosome-containing nongrow-
ing dormant bacteria (Fig. 4E). Single-copy tagged alleles of genes
encoding SPI-2 proteins were used to analyze effector production
and subcellular location. Thus, we could not rule out that the
different subcellular distribution observed for PipB in fibroblasts
compared to that in epithelial cells resulted from the fact than in
epithelial cells, this effector has been analyzed only upon ectopic
FIG 2 Involvement of a subset of SPI-2 effectors in maintenance of S. Typhi-
murium viability inside fibroblasts. Shown is the ratio between numbers of
viable intracellular bacteria counted at 24 h versus those at 2 h postinfection
of NRK-49F fibroblasts for each of the indicated strains relative to the ratio of
wild-type bacteria, which had an average of 5.3 in three independent experi-
ments. Note the overgrowing phenotype displayed by the phoPmutant and the
requirement of SseF, SseG, and SseJ for viability maintenance. The ssaV mu-
tant, lacking a structural protein of the secretion apparatus, was used as the
negative control for secretion via the SPI-2 TTSS. Data represent the means
and standard deviations from three independent experiments. ***, P 0.001;
n.s., not significant by a one-way ANOVA with Tukey’s posttest.
FIG 3 SPI-2 effector SseJ is distributed along the membranous system of the infected cell to a lesser extent in fibroblasts than in epithelial cells. Shown are
immunofluorescence microscopy images of NRK-49F fibroblasts and HeLa epithelial cells infected with the S. Typhimurium chromosomally tagged strain
sseJ::3FLAG for 24 and 6 h, respectively. The distribution of the endogenous tagged SseJ-3FLAG protein was examined with anti-FLAG antibodies. Note the
distinct pattern between host cell types even with similar numbers of intracellular bacteria. Arrows point to intracellular bacteria located inside the fibroblasts,
and the arrowheads point to SseJ present in filamentous membranous structures of HeLa epithelial cells.
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overexpression (62). To test this possibility, the pipB::3FLAG-
tagged strain was used to infect HeLa epithelial cells. In contrast to
fibroblasts, the tagged PipB-3FLAG protein was visualized in
phagosomal and extraphagosomal locations as well as in filamen-
tous structures of HeLa-infected cells (Fig. 4F). Of interest, PipB-
3FLAGwas also observed in extraphagosomal locations in over-
growing phoPmutant colonizing fibroblasts, although in this case
no filamentous structures containing the effector were visible
(data not shown). Taken together, these observations demon-
strated that the confinement of the PipB effector to the phago-
somal region upon translocation is a phenomenon occurring in
nongrowing dormant bacteria.
Similar experiments were performed with a pipB2::HA chromo-
somally tagged strain. In this case, much smaller amounts of the
PipB2-HA-tagged protein were detected in nongrowing dormant
wild-type bacteria, and no obvious subcellular location could be as-
signed for this effector upon fibroblast infection (Fig. 5A). Fraction-
ation experiments suggested that, similar to PipB, PipB2 secretion
was limited to the phagosomal compartment, since no PipB2 was
detected in the P2 fraction (membranous material) or the cytosol
upon mechanical rupture of infected fibroblasts (Fig. 5B). A small
amount of the effector could be visualized upon 1% Triton X-100
treatment (Fig. 5C), suggesting that part of the PipB2-HAmolecules
produced by dormant bacteria could be secreted. PipB2 was visual-
ized in large amounts in phagosomal and extraphagosomal locations
in fibroblasts infected with the phoP pipB2::HA mutant (data not
shown). It was noteworthy that, unlike the response exhibited in fi-
broblasts, wild-type bacteria secreted large amounts of chromo-
somally tagged PipB2::HA into membranous structures of HeLa ep-
ithelial cells (Fig. 5D). Altogether, these findings indicated that PipB2
is an effector produced and translocated by dormant nongrowing
intracellular S. Typhimurium in small amounts inside fibroblasts,
and that it does not traffic to extraphagosomal or filamentous struc-
tures of the infected cell.
FIG 4 SPI-2 effector PipB is translocated by nongrowing dormant intracellular S. Typhimurium to phagosome-confined regions. (A) Distribution of endoge-
nous chromosomally tagged PipB-3FLAG in NRK-49F fibroblasts at 24 h postinfection. Arrows indicate four fields containing intracellular bacteria that are
magnified in panel B. (B)Magnified images of fields selected from panel A showing the distribution of PipB-3FLAG in dormant intracellular bacteria. Note the
lack of effector labeling in some bacteria. (C)Mechanical fractionation denotes that endogenous PipB-3FLAG is not released to the endomembrane system. P1,
nuclear/bacterial fraction; P2, high-speed particulate material, membranous fraction; S2, cytosol, soluble fraction (see Materials and Methods for details). (D)
Translocation of PipB-3FLAGbynongrowing dormant intracellular bacteria shownby the detection of the effector in a subcellular fraction containingmaterial
solubilized with 1% (vol/vol) Triton X-100. P, pellet, material insoluble in detergent; S, material solubilized with the detergent. (E) Triple labeling showing that
the distribution of PipB-3FLAG inNRK-49F fibroblasts is observed inside that of amembranemarker positioned in the phagosomalmembrane, a glycoprotein
recognized by the mouse monoclonal 5G10 (64). (F) Distribution of endogenous PipB-3FLAG in HeLa epithelial cells at 6 h postinfection. Note that PipB
shows a distribution confined to the phagosomal region exclusively in nongrowing dormant bacteria located inside fibroblasts.
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NongrowingS. Typhimuriumdiscriminates amongSPI-2 ef-
fectors for production and translocation inside fibroblasts. The
data described above evidenced twomajor differences concerning
the biology of SPI-2 effectors when S. Typhimurium colonizes
fibroblasts or epithelial cells. First, at least two of the three SPI-2
effectors analyzed (PipB and PipB2) were distributed in the pha-
gosomal area to a greater extent in fibroblasts than in epithelial
cells (Fig. 4 and 5). Second, unlike the case for epithelial cells, the
lack of individual SPI-2 effectors compromises the viability of
intracellular bacteria (Fig. 2). Based on these observations, we
sought to determine whether S. Typhimurium could discriminate
SPI-2 effectors to adapt to a nongrowing intracellular lifestyle. For
this purpose, different SPI-2 effectors taggedwith theM45 epitope
of the adenovirus protein E4-6/7 (65) were expressed in trans.
These effectors included SifA-M45, SifB-M45, SseJ-M45, SseF-45,
and SseG-M45 (24, 45), which are produced by bacteria growing
in LB (Fig. 6A). Under this growth condition, it has been shown
that bacteria do not secrete any of these SPI-2 effectors (66). Se-
cretion of these M45-tagged effectors was reported to occur in
extracellular bacteria growing in acidified minimal medium (66).
In fibroblasts, nongrowing dormant bacteria produced all of these
SPI-2-tagged effectors (Fig. 6B). However, only SseF-M45 and
SseJ-M45 were observed in subcellular fractions containingmate-
rial solubilized with a low concentration of a nonionic detergent,
1% (vol/vol) Triton X-100 (Fig. 6B). Such translocation was de-
pendent on an active SPI-2 TTSS, since it was not observed in the
ssaV mutant (Fig. 6C). Control experiments with bacteria grown
extracellularly discarded that the Triton X-100 treatment ex-
tracted SseF and SseJ from intact bacteria (Fig. 6D). Thus, we
concluded that SseF and SseJ are efficiently translocated by intra-
FIG 5 Limited translocation of the SPI-2 effector PipB2 in nongrowing intracellular S. Typhimurium. (A) Distribution of endogenous chromosomally tagged
PipB2-HA inNRK-49F fibroblasts at 24 h postinfection. (B)Mechanical fractionation denotes that endogenous PipB2-HA is not released to the endomembrane
system. P1, nuclear/bacterial fraction; P2, high-speed particulate material, membranous fraction; S2, cytosol, soluble fraction (see Materials and Methods for
details). (C) PipB2 is translocated by dormant intracellular bacteria, as denoted by its detection in a subcellular fraction containing material solubilized with 1%
(vol/vol) Triton X-100. (D) Distribution of endogenous PipB2-HA in HeLa epithelial cells at 6 h postinfection. Arrows indicate the presence of the effector in
endomembranous filamentous structures.
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cellular S. Typhimurium inside fibroblasts when overexpressed in
trans. Strikingly, no translocation was observed for SifA, SifB, or
SseG (Fig. 6B). This difference could be due to a distinct stability
of the translocated effector dictated by the host cell type or to a
relatively low level of production, as seems to be case for SseG.
Experiments in which a protease inhibitor was used ruled out an
action of proteases on translocated SifA-M45 or SifB-M45 (Fig.
6E). When tested in HeLa epithelial cells, SifA-M45, SifB-M45,
and SseG-M45 were efficiently translocated when overexpressed
on an individual basis (Fig. 6F). Similar to the data obtained in
fibroblasts, SseJ-M45 and SseF-M45 are efficiently translocated by
bacteria proliferating inside HeLa cells (Fig. 6F). Thus, with the
exception of SseG-M45, which was barely detected in nongrowing
dormant bacteria-colonizing fibroblasts (Fig. 6B), these results
demonstrated that bacteria persisting inside fibroblasts are not
competent for secreting SifA or SifB evenwhen these two effectors
are artificially overproduced in trans. These observations led us to
examine whether overproduction of SPI-2 effectors that were ef-
ficiently translocated in fibroblasts, such as SseJ, could have dif-
ferent consequences for the bacterial fate compared to those effec-
tors remaining inside the bacteria (SifB). Microscopy analyses
performed in NRK-49F fibroblasts revealed that intracellular bac-
teria overexpressing SseJ-M45 were in much larger numbers, and
that this effector localized in phagosomal and extraphagosomal
locations, including filamentous structures resembling Sifs (Fig.
7A), defined by some authors as globular membranous compart-
ments (56). Importantly, increased proliferationwas not observed
in bacteria overexpressing an SPI-2 effector not efficiently trans-
located, such as SifB (Fig. 7A). Quantification of bacterial loads in
fibroblasts infected with these strains also denotes a significant
increase in bacterial proliferation upon SseJ translocation (Fig.
7B). Altogether, these data supported the idea of nongrowing dor-
mant intracellular S. Typhimurium translocating only a discrete
subset of SPI-2 effectors upon entry into fibroblasts. Moreover,
the data suggested that the amount of effector secreted must be
finely adjusted to ensure control of the intracellular growth rate.
DISCUSSION
In this study, we analyzed the contribution of SPI-2 to the persis-
tence state that S. Typhimurium mounts upon entry into fibro-
FIG 6 Nongrowing dormant intracellular S. Typhimurium is competent for translocating only defined SPI-2 effectors inside fibroblasts. (A) Expression of
M45-tagged SPI-2 effectors in extracellular S. Typhimuriumuponovernight growth at 37°C in LBmediumat neutral pHunder nonshaking conditions. Indicated
are the respective SPI-2 effectors analyzed. (B) Selective translocation of tagged SseF-M45 and SseJ-M45 effectors occurs in nongrowing dormant intracellular
fibroblasts. Note that there is no translocation of SifA-M45 or SifB-M45, even when there is prominent production of both effectors. (C) Control assays
demonstrating that SseF-M45 and SseJ-M45 translocation depends on a functional SPI-2 TTSS. (D) Extraction of M45-tagged SPI-2 effectors in extracellular S.
Typhimurium in buffer containing 1% (vol/vol) TritonX-100. Note the negligible amount of the bacterium-associated effector extracted by the detergent, which
contrasts with the amount of effector detected outside the bacteria in infected fibroblasts (Fig. 4B and 5B). (E) Translocation rate of the effectors SifA, SseJ, and
SifB in intracellular bacteria infecting NRK-49F fibroblasts pretreated for 30 h with a protease inhibitor cocktail or left untreated. (F) Efficient translocation of
M45-tagged SseF, SseG, SifA, SifB, and SseJ by intracellular bacteria proliferating inside HeLa epithelial cells.
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blasts. Unlike the case in other host cell types, in fibroblasts this
pathogen utilizes distinct regulators to attenuate intracellular
growth. One of these regulators, the two-component system
PhoP-PhoQ, is linked to the fine tuning of SPI-2 gene expression
(reviewed in reference 18). Our former studies in fibroblasts re-
vealed that the lack of SPI-2 causes loss of viability of nongrowing
dormant bacteria, whereas a nonfunctional PhoP-PhoQ system
led to exacerbated intracellular bacterial growth (36). Based on
these findings, we examined the relationship between SPI-2 and
PhoP-PhoQ in the fibroblast infection model and also implicated
the OmpR-EnvZ system, known to play an important role in
SPI-2 induction (14, 41, 67). Usage of chromosomally tagged
strains proved to be a convenient strategy to monitor in a timely
fashion SPI-2 induction based on the detection of physiological
levels of the SPI-2 regulator SsrB. In a previous study, Xu and
Hensel analyzed the kinetics of induction of the SPI-2 regulon
using luciferase-based transcriptional fusions in bacteria grown in
PCN, a minimal defined medium that mimics SPI-2-inducing
conditions (68). Consistent with the protein data reported here
for nongrowing dormant intracellular bacteria, these authors
noted a delayed expression of the SPI-2 regulon in the phoP mu-
tant, a phenomenon not observed in other mutant backgrounds,
such as ompR-envZ or slyA (68). This trend was reproduced in
different luc fusions, such as sseJ::luc, sifA::luc, and sseA::luc, but
the basis of this temporal regulation was not investigated further.
In our work, the apparent delayed expression of the SPI-2 regulon
exhibited by the phoP mutant correlates with exacerbated bacte-
rial growth. Importantly, we were able to detect differences at the
protein level between nongrowing dormant wild-type bacteria
and overgrowing phoP bacteria, as was the case for SseJ, which is
produced at slightly higher levels by the phoP mutant at late
postinfection times (Fig. 1). Since we did not investigate all pre-
dicted and known SPI-2 effectors, it cannot be discarded that the
exacerbated growth exhibited by the phoPmutant results from an
altered production and/or secretion of SPI-2 effectors at defined
postinfection times. For the ompR mutant, the major defect ob-
served was the inability of the bacteria to produce normal
amounts of SsrB and SPI-2 effectors (Fig. 1). This erroneousman-
ner of inducing the SPI-2 regulon could explain the mild increase
in bacterial growth rate observed for the ompR mutant inside
fibroblasts (36).
An unexpected result of our study was the apparent discrimi-
nation of SPI-2 effectors relative to the role played by SPI-2 in
survival of nongrowing dormant intracellular bacteria (36). These
differences are not obvious in other nonphagocytic cells, such as
epithelial cells, in which it has not yet been determinedwhether all
or only a subset of SPI-2 effectors are produced and translocated
upon bacterial entry. In the epithelial cell infection model, some
studies showed that null mutants with global defects in the SPI-2
regulon, such as the ssaR mutant, do not exhibit any phenotype
(47). In other cases, a role of SPI-2 effectors, such as SseF and
SseG, in promoting bacterial growth inside epithelial cells was
claimed (48, 49). Remarkably, the same study that investigated in
a comprehensive manner the role of individual SPI-2 effectors in
epithelial cellsmonitored the phenotype of the respectivemutants
in macrophages, as well as in organs and in the presence of bile
FIG 7 Increased translocation of SseJ results in augmented proliferation of S. Typhimurium inside NRK-49F fibroblasts. (A) Immunofluorescence microscope
images denoting the increased proliferation of intracellular bacteria overexpressing the SseJ-M45-tagged effector. Note that the phenomenon is accompanied by
the formation of globular filamentous structures containing the effector that resemble Sifs (arrows). None of these effects were observed in intracellular wild-type
overexpression of the SPI-2 effector SifB-M45. (B) Quantification of these phenotypes was performed by enumeration of intracellular bacteria in each cell,
counting aminimum of 100 infected fibroblasts. Shown are the combined data from two independent experiments. , P 0.01 to 0.05; , P 0.001 to 0.01 (by
a one-way ANOVA with Tukey’s posttest). Note the significant increase in bacterial proliferation upon SseJ overexpression.
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(47). In RAW264.7 macrophages, the data implicated SPI-2 effec-
tors such as SifA and SifB in bacterial replication/survival but did
not reveal any change for mutants lacking SseF or SseG. More
recently, the lack of SPI-2 effectors, such as SifA, SseJ, SopD2,
SseG, SseF, and SrfH, has been reported to affect the capacity of S.
Typhimurium to proliferate within mouse bone marrow-derived
macrophages (69). Of these effectors, SseJ, SseG, and SseF play an
important role in survival of nongrowing dormant bacteria lo-
cated in fibroblasts. Despite this apparent similarity, differences
between fibroblasts and cultured macrophages are likely to exist,
since in the former cells SPI-2 is used by intracellular S. Typhimu-
rium mainly for survival rather than for proliferation (36, 61).
Our study also shows that SifA is dispensable for intracellular sur-
vival, inmarked contrast to the key role of this effector in bacterial
growth inside macrophages (47, 69). Interestingly, a recent study
by Grant et al. reported a role of SPI-2 in negatively modulating
the growth rate in vivo in phagocytic cells (37). Therefore, the
analysis of phenotypes shown by S. Typhimurium in fibroblasts
may provide new insights into how this pathogen establishes a
nonproliferative intracellular state and the extent to which the
lifestyles that the pathogen adopts in fibroblasts and phagocytes
are comparable.
To our knowledge, this study uncovered a fact not previously
reported for any SPI-2 effector: the possibility of reaching differ-
ent final destinations depending on the type of host cell that is
colonized. The limited distribution observed for all SPI-2 effectors
tested in persistently infected fibroblasts compared to that of epi-
thelial cells may result from different dynamics in the vesicular
traffic directed to or emanating from the SCV. Thus, the proxim-
ity of the SCV to the microtubule organizing center and the Golgi
apparatus reported to occur in epithelial cells (48, 49) is a rare
phenomenon in fibroblasts (our unpublished data). Such proxim-
ity to the Golgi apparatus following the subversion of key motor
proteins, such as kinesin and dynein, by dedicated SPI-2 effectors
(70–72) is fundamental for S. Typhimurium proliferation. This
phenomenon is not prominent in bacteria located in fibroblasts,
with the SCV maintaining a scattered distribution in the infected
cell long after bacterial entry (our unpublished data). Since the
data reported here sustain an important role of SPI-2 effectors
previously linked to SCV positioning in survival of dormant bac-
teria located in fibroblasts, it is tempting to speculate that the
effectors SseJ, SseF, and SseGplay different roles depending on the
host cell type that is colonized. On the other hand, SifA, an SPI-2
effector that plays a master role in subversion of kinesin activity
and SCV positioning in epithelial cells (72), is dispensable in
fibroblast cells for intracellular survival. Overall, these data sup-
port the idea that differences exist in the trafficking and biogenesis
of the SCV in distinct nonphagocytic cell types.
Lastly, the data reported here allow us to tentatively hypothe-
size why S. Typhimurium, as well as many other intracellular
pathogens, has such a vast repertoire of effector proteins that
evolved to subvert host cell functions. The fact that in fibroblasts
certain effectors, such as SifA and SifB, are not translocated by
nongrowing intracellular bacteria even upon their artificial pro-
duction fromplasmids suggests that the SPI-2 secretion apparatus
displays permissiveness for only certain protein effectors depend-
ing on the host cell type that is colonized. Such permissiveness
could be dictated by signals coming from the host cell type. The
molecular details for such restriction in protein secretion is chal-
lenging, considering that the available transcriptomic data infer
activity of the SPI-1 secretion apparatus in S. Typhimurium per-
sisting inside fibroblasts (29). Cross-talk between the two type III
secretion systems is also inferred by the existence of effectors that
can be recognized in vitro as substrates by both apparatuses (23)
and by the interconnected role of SPI-1 regulators acting on SPI-2
(21, 22). Future analyses should address how communication be-
tween the infected host cell and intracellular S. Typhimurium can
lead to utilization of a defined subset of SPI-2 effectors for
ensuring the survival of nongrowing dormant intracellular
bacteria.
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